Contract Research
Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine
First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...
September 11, 2021 | News
Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)
As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, environment and anti-corruption,...
August 27, 2021 | News
BioAgilytix to Purchase Australia-based 360biolabs®
BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all sta...
August 17, 2021 | News
ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App
The initial spark of an idea that would eventually become ClinTex started in 2014, at the DIA Forum in Vienna. By 2018, Clintex was formally working on the...
August 05, 2021 | News
CliniRx to offer full suite of Rave EDC and CDM services to sponsors
CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...
July 30, 2021 | News
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility
Marker Therapeutics, Inc. a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapi...
July 30, 2021 | News
Novotech Joins (DTRA) to Accelerate Clinical Trials
The "Decentralized Trials & Research Alliance(DTRA)" ( https://www.dtra.org/ ), which was launched in December, 2020, is uniting in...
July 21, 2021 | News
Frost & Sullivan recognizes leading global CRO Parexel
The company employs real-world data and evidence to accelerate research through targeted site and patient recruitment strategies Based on its rece...
July 20, 2021 | News
Novotech expands virtual clinical trials capabilities
The round was led by two new partners: Dedalus Group a leading healthcare and diagnostic software provider in Europe backed by Ardian, and Novotech H...
July 19, 2021 | News
Inotiv Acquires Genetic Toxicology Assets from Merck's BioReliance® portfolio
Robert Leasure, Jr., President and CEO of Inotiv, commented, “This transaction with MilliporeSigma adds genetic toxicology to our suite of internal c...
July 14, 2021 | News
Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia
Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...
July 08, 2021 | News
Medidata to Offer Secure Platform for Decentralization of Clinical Trials
The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...
June 16, 2021 | News
WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates
Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...
June 10, 2021 | News
21% were not aware Australian data is accepted by the FDA and other major regulatory authorities
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...
June 04, 2021 | Analysis
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
